Participated · Series A · Jul 2026

Founded in 2020 in Toulouse, Bohr Énergie operates a proprietary platform that combines software, AI, algorithms, production forecasting, market analysis and regulatory expertise to enable optimisation and commercialisation of distributed renewable and flexible assets. As an independent aggregator it manages solar, wind, hydro, batteries and hybrid systems, enabling asset owners to participate in electricity markets. The firm currently has more than 170 renewable and flexible assets in its portfolio and expects to reach close to 1 GW under management by the end of the year. Management plans to use the Series A capital to consolidate its French position, accelerate platform development and launch additional services. Bohr has signalled international expansion with Spain and Italy among its priority markets.

Participated · Series F · Apr 2017

Zeta Global builds a data-driven marketing platform that combines companies' first-party data with AI and an identity graph of more than 2.4 billion customer identifiers to personalize messages and offers. The company emphasizes use of predictive AI and identity-based data to help marketers engage customers across the digital ecosystem. Zeta has used prior financing to make acquisitions and integrations, including Disqus and Boomtrain, and the team says it continues to "organically innovate." Leadership frames recent market trends as a "five-year acceleration" toward data-centric digital transformation. Current plans highlighted by management include continued focus on the customer data platform and connected TV capabilities. The firm has previously used both equity and debt financing as part of its capital strategy. Zeta Global is a marketing tech company that brings data analysis to CRM and multi-channel marketing across both in-store and e-commerce channels. Its product portfolio spans CRM services and multi-channel marketing solutions, and its enterprise customers include Sprint, UPS, IKEA, American Airlines, British Airways, PayPal and the NFL. The company has grown through acquisitions, including eBay’s enterprise arm and Acxiom Impact, and plans further acquisitions and investments in its technology. Zeta is profitable and has a history of tapping the debt market to finance acquisitions, typically making about one acquisition per year. After the latest round its total funding exceeds $250 million and the company’s valuation is reported at about $1.3 billion. CEO David Steinberg is monitoring the IPO market and says Zeta could pursue an IPO if conditions are strong, or use cash to buy undervalued companies if markets weaken. Zeta Interactive operates a big-data marketing platform that combines marketing automation, email and social tools with analytics and machine-learning capabilities. The company says it has over 570 enterprise customers and is valued at over $1 billion. Zeta reported being "very profitable" and doing over $300 million a year in revenue, growing 75% since its last equity round. Leadership emphasizes integrating acquisitions rather than running them as separate divisions. Recent acquisition activity includes the CRM division of eBay Enterprise, ClickSquared and a machine-learning-focused division of Adchemy. Future plans include more machine-learning capabilities, additional marketing display technologies, further acquisitions and an eventual IPO within a year or two. Zeta Interactive offers a suite of data-driven marketing solutions—Data, Email, Social, Display, Search and Mobile—powered by big data, analytics and machine learning to help brands acquire, grow and retain customers. The company serves hundreds of Middle Market and Fortune 500 brands and has grown through acquisitions, including marketing automation platform ClickSquared and the Actions division of Adchemy with its patented machine learning platform. Zeta employs over 600 people worldwide with offices in NYC, Silicon Valley, London, Hyderabad and several additional U.S. and UK locations. Founded in 2007 by David A. Steinberg and John Sculley, the company intends to use new financing to enhance and expand its platform, increase market penetration in the U.S. and U.K., and accelerate a strategic acquisition strategy. The recent financing provides additional capital to support product development and growth initiatives. No revenue or user metrics were disclosed in the article.

Participated · Equity · Apr 2012

LNC Therapeutics, based in Bordeaux, France, develops gut microbiota-directed drugs targeting obesity and associated cardiometabolic diseases. Its programs encompass fundamental research, preclinical studies and clinical trials. The company is led by CEO Jean-Luc Treillou and CSO Sandrine Claus, PhD. LNC raised €6.5m in a Series C to continue and expand its development efforts. Prior funding includes €1.5m in grants from French BPI and the Aquitaine Region. To date the company has raised a total of €16.5m.